Coverage has been significantly strengthened across key therapeutic categories, including anti-tubercular, anti-diabetic and anti-cancer medicines, as well as iron supplements, thereby ensuring more comprehensive standardisation of medicines used under various National Health Programmes
Under his leadership, Chidamide became China’s first original small-molecule anti-tumor innovative drug and the country’s first pharmaceutical product globally licensed out
The partnership also sets the stage for broader collaboration on rare disease treatments
Lucid-MS represents a potential breakthrough in the treatment of multiple sclerosis
For 2026 onwards, CPHI and PMEC India are evolving into two distinct, specialized shows
Indian Pharmacopoeia is now recognised in 19 countries, reflecting growing international confidence in India’s regulatory and scientific capabilities
CLE, a common form of lupus erythematosus, primarily causes diverse skin lesions
The new single-use commercial facility will be among India’s largest, featuring advanced technologies to produce high-quality biologics and specialty pharmaceuticals
The opening of our 1000th pharmacy in Karnataka marks an important step
These observations are procedural in nature and the company does not anticipate any impact on supply of its commercial products
Subscribe To Our Newsletter & Stay Updated
